The Fraunhofer USA team will partner with a Fraunhofer Society institute in Germany in order to reduce the cost for its patented microchip that detects viruses including Ebola.
In PLOS this week: approach to diagnose hemorrhagic fevers, recessive disease mutations in mixed-breed dogs, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
The German company said the open-access platform, called Pharos V8, can provide real-time PCR results in 10 minutes.
An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent.
Presenters at ASM have used next-generation sequencing to examine Ebola, Zika, and respiratory virus infection and transmission.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
In Nature this week: reverse genetics used to gauge phenotypes of loss-of-function mutations, and more.
The virus spread according to a gravity model between large population centers, and its movements were affected by geographical distance.
In Genome Biology this week: epigenetic differences in CML cells, predicting aggressive prostate cancer, and more.
Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.
Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.
Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.
In Nature this week: sequenced genomes of five additional Neanderthals, and more.